Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN)

CUSIP: 29337E102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
58,923,077
Total 13F shares
49,624,914
Share change
+1,247,117
Total reported value
$1,116,597,658
Put/Call ratio
27%
Price per share
$22.50
Number of holders
111
Value change
+$24,828,957
Number of buys
58
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 29337E102?
CUSIP 29337E102 identifies ELVN - Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN) as of Q4 2024

As of 31 Dec 2024, Enliven Therapeutics, Inc. - Common Stock, par value $0.001 per share (ELVN) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,624,914 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, COMMODORE CAPITAL LP, VR Adviser, LLC, Fairmount Funds Management LLC, BlackRock, Inc., Polar Capital Holdings Plc, VANGUARD GROUP INC, CITADEL ADVISORS LLC, and 5AM Venture Management, LLC. This page lists 111 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.